/

Ring Therapeutics

Developing redosable gene therapies using human commensal virus vectors.

BiotechnologyHealthcare ringtx.com ↗

Company facts

Founded: 2017
Employees: 111
Headquarters: United States
Type: Private
Funding: Series C · $86.5M · 2023